Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.132 EUR | +2.28% | +11.54% | +72.35% |
06-27 | Hansa Biopharma AB Announces Board Appointments | CI |
05-31 | Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial | MT |
- Stock Market
- Equities
- HNSA Stock
- 24H Stock
- News Hansa Biopharma AB